Interventions promoting cognitive function in patients experiencing cancer related cognitive impairment: A systematic review

Psychooncology. 2023 Feb;32(2):214-228. doi: 10.1002/pon.6073. Epub 2022 Dec 14.

Abstract

Objective: To examine the effect of interventions used to enhance cognitive function in patients experiencing cancer-related cognitive impairment.

Methods: Studies including adults with a non-metastatic cancer who have received chemotherapy as part of their treatment and who have undergone interventions targeting cancer-related cognitive impairment were included. Studies involving patients with metastatic cancer and pre-existing cognitive deficits were excluded. Academic Search Complete, CINAHL Plus with full text, MEDLINE, Education Full Text, PsycARTICLES, PsycINFO, and ERIC were searched for studies published between January 2011 and September 2022. Data extraction and quality appraisal were conducted by two authors and cross-checked by the review team. Quality appraisal was conducted using 12 items from the Mixed Methods Appraisal Tool. Findings were presented narratively without meta-analysis.

Results: Thirty-one studies were included. Interventions were categorised as integrative/complementary, cognitive behavioural therapy and compensatory strategies, exercise, psychoeducational/psychosocial, brain-training, and pharmacological. Over 100 instruments were identified, including the Functional Assessment of Cancer Therapy-Cognitive, Trail Making Tests-A and B, and instruments measuring secondary outcomes, including depression. Instruments often measured attention and concentration, language, memory, executive function, and/or patient-reported outcomes. Improvements were reported, with most studies measuring some or various aspects of cognitive functioning and very few studies measuring all domains of cognitive functioning, making it difficult to draw definitive conclusions about effectiveness.

Conclusions: Various interventions are available to treat cancer-related cognitive impairment. Outcome measurement was inconsistent and future research should prioritise using standardised measures. Current evidence, whilst not being definitive, suggests that certain interventions show greater promise than others, including cognitive behavioural therapy and brain training.

Keywords: antineoplastic agents; cancer; chemotherapy-related cognitive impairment; cognitive dysfunction; memory; oncology; survivorship; systematic review.

Publication types

  • Systematic Review
  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cognition
  • Cognition Disorders* / etiology
  • Cognition Disorders* / therapy
  • Cognitive Dysfunction* / etiology
  • Cognitive Dysfunction* / therapy
  • Executive Function
  • Humans
  • Neoplasms* / complications
  • Neoplasms* / therapy